Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing standing type 1 diabetes

被引:40
作者
Molitch, ME
Rupp, D
Carnethon, M
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.2337/diacare.29.01.06.dc05-1583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria. RESEARCH DESIGN AND METHODS - We analyzed the lipid profiles of patients with type I diabetes of >= 20 years duration in 42 patients With albuminuria (28 microalbuminuria and 14 macroalbuminuria) and 65 patients without increased albumin excretion before any interventions with either statins or ACE inhibitors. RESULTS - Several characteristics were similar in the two groups: sex, age, duration of diabetes, total cholesterol, LDL cholesterol, and triglycerides. By univariate analysis, significant differences (P < 0.01) were found in HDL cholesterol (albuminuria 1.42 mg/dl, no albuminuria 1.71 mg/dl, P < 0.01), HbA(1c) (AlC) (albuminuria 8.5%, no albuminuria 7.5%), and proportions with no, background, and proliferative retinopathy (albuminuria 2.4, 16.7, and 81%; no albuminuria 24.6, 52.3, and 23.1%, respectively). When adjusted for age and sex, a 0.26-mmol/l (10-mg/dl) increase in HDL cholesterol is associated with an odds ratio (OR) of 0.70 (95% CI 0.54-0.90) for having albuminuria. In a multivariate model that adjusted for age, sex, diabetes duration, and AlC, for every 0.54-mmol/l (21-mg/dl) increase in HDL cholesterol, patients are approximately half (OR 0.51 [95% CI 0.30-0.86]) as likely to have albuminuria, even after controlling or AlC. CONCLUSIONS - Higher HDL cholesterol levels may be protective against the development of albuminuria in patients with type I diabetes. Whether this is due to the HDL cholesterol levels or whether they serve as a marker for some other mechanism remains to be determined.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 44 条
[1]   Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort) [J].
Bain, SC ;
Gill, GV ;
Dyer, PH ;
Jones, AF ;
Murphy, M ;
Jones, KE ;
Smyth, C ;
Barnett, AH .
DIABETIC MEDICINE, 2003, 20 (10) :808-811
[2]   THE EFFECT OF PROTEINURIA ON RELATIVE MORTALITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
ANDERSEN, PK ;
DECKERT, T .
DIABETOLOGIA, 1985, 28 (08) :590-596
[3]   Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy [J].
Breyer, JA ;
Bain, RP ;
Evans, JK ;
Nahman, NS ;
Lewis, EJ ;
Cooper, M ;
McGill, J ;
Berl, T ;
Rohde, R ;
Hunsicker, LG ;
Lachin, J ;
Greenhouse, SW ;
Verme, DA ;
Turlington, TR ;
Burrows, PK ;
Wish, J ;
Sheehan, J ;
Pohl, M ;
Berl, T ;
Santiago, G ;
Hunsicker, L ;
Kern, EFO ;
Lemann, J ;
Blementhal, S ;
Bresnahan, BS ;
Hebert, L ;
Goldfarb, S ;
Kobrin, S ;
Rodby, R ;
Levey, A ;
McLaughlin, M ;
Williams, M ;
McGill, J ;
Whittler, F ;
Rutecki, G ;
Cattran, D ;
Lietz, S ;
Valaitis, D ;
Hano, J ;
Maxwell, D ;
Porush, J ;
Spitalewitz, S ;
Shapiro, K ;
Adler, S ;
Tolchin, N ;
Hoy, W ;
Bernstein, R ;
Svetkey, L ;
Sharon, Z ;
Rausenbaum, B .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1651-1658
[4]   Factors associated with microalbuminuria in Type 1 diabetes mellitus:: a cross-sectional study [J].
Campos-Pastor, MM ;
Escobar-Jiménez, F ;
Mezquita, P ;
Herrera-Pombo, JL ;
Hawkins-Carranza, F ;
Luna, JD ;
Azriel, S ;
Serraclara, A ;
Rigopoulos, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 48 (01) :43-49
[5]   The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[6]   Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes [J].
Chaturvedi, N ;
Fuller, JH ;
Taskinen, MR .
DIABETES CARE, 2001, 24 (12) :2071-2077
[7]   Genetic determinants of diabetic nephropathy [J].
Chowdhury, TA ;
Dyer, PH ;
Kumar, S ;
Barnett, AH ;
Bain, SC .
CLINICAL SCIENCE, 1999, 96 (03) :221-230
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26 [J].
Cusick, M ;
Chew, EY ;
Hoogwerf, B ;
Agrón, E ;
Wu, L ;
Lindley, A ;
Ferris, FL .
KIDNEY INTERNATIONAL, 2004, 66 (03) :1173-1179
[10]  
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703